Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
Fish and Richardson
Dow
Chubb
Covington
Fuji
Healthtrust

Generated: April 25, 2018

DrugPatentWatch Database Preview

PROMETH VC PLAIN Drug Profile

« Back to Dashboard

Which patents cover Prometh Vc Plain, and when can generic versions of Prometh Vc Plain launch?

Prometh Vc Plain is a drug marketed by G And W Labs Inc and is included in one NDA.

The generic ingredient in PROMETH VC PLAIN is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for PROMETH VC PLAIN
Drug patent expirations by year for PROMETH VC PLAIN
Synonyms for PROMETH VC PLAIN
956596-27-3
DTXSID80241919
Phen-Tuss AD Syrup
Phenylephrine and Promethazine Syrup
Phenylephrine mixture with promethazine
Prometh VC Plain Syrup
Promethazine Hydrochloride and Phenylephrine Hydrochloride Syrup
PROMETHAZINE VC PLAIN
Promethazine VC Plain Syrup
SCHEMBL2526853

US Patents and Regulatory Information for PROMETH VC PLAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc PROMETH VC PLAIN phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 088761-001 Nov 8, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Daiichi Sankyo
McKinsey
Teva
Citi
Fuji
Harvard Business School
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.